FindTrial
Sign In

Analysis of Risk Factors for Recurrence and Development of a Prediction Model for WHO Grade II Meningioma: A Multicenter Cohort Study

Analysis of Risk Factors for Recurrence and Development of a Prediction Model for WHO Grade II Meningioma: A Multicenter Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110557
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningioma

Interventions

Observation group:None

Sponsors

Tangdu Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Retrospectively collect patients aged >18 years with a histopathologic diagnosis of WHO grade II meningioma treated at Guangdong Sanjiu Brain Hospital, Beijing Tiantan Hospital (Capital Medical University), First Affiliated Hospital of Zhengzhou University, Shanxi Provincial People’s Hospital, First Affiliated Hospital of Air Force Medical University, and Second Affiliated Hospital of Air Force Medical University between January 2018 and December 2023.

Exclusion criteria

Exclusion criteria: Patients aged under 18, those unwilling to participate, and those with a histopathologic diagnosis of grade I or III meningioma.

Design outcomes

Primary

MeasureTime frame
Recurrence;—

Countries

China

Contacts

Public ContactTianzhi Zhao

Tangdu Hospital, Fourth Military Medical University

zhaotianzhi1981@163.com+86 135 7192 4255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026